Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
soreness at the injection site; headaches; body aches; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced injection site pain (Verbatim: soreness at the injection site), headache (Verbatim: headaches) and general body pain (Verbatim: body aches). The outcome of the injection site pain, headache and general body pain were not reported. It was unknown if the reporter considered the injection site pain, headache and general body pain to be related to RSV vaccine. It was unknown if the company considered the injection site pain, headache and general body pain to be related to RSV vaccine. Additional Information: GSK Receipt Date: 16-APR-2025 This case was reported by a patient via interactive digital media. The soreness at the injection site, some headaches and body aches. Actually, some of the mildest problems of all the vaccines. The alternative was horrible sickness or death. Easy decision.